Showing 1-10 of 14 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Translational Development of ILC210 Therapy for Islet Transplantation | BC Cancer, part of Provincial Health Services Authority | Sarah Crome | Cures | 01-October-2026 to 30-September-2029 | $1.083.000,00 |
| Development of an antigen-specific lipid nanoparticle mRNA therapy for T1D | Integrated Nanotherapeutics, Inc | Chris Tam | Cures | 01-June-2024 to 30-November-2026 | $750.000,00 |
| Using a virtual care platform to deliver peer-led mental health support to rural and remote communities in BC: A randomized wait-list controlled trial of the REACHOUT intervention | The University of British Columbia | Tricia Tang | Improving Lives | 01-September-2022 to 31-December-2026 | $402.429,50 |
| RREB1 and Ras signalling in cytokine-induced beta cell death | The University of British Columbia | Nicole Krentz | Cures | 01-March-2026 to 28-February-2031 | $1.000.000,00 |
| CAR Tregs to induce islet transplant tolerance | The University of British Columbia | Megan Levings | Cures | 01-October-2026 to 30-September-2029 | $899.999,91 |
| Harmonizing biomarkers in clinical trials of ustekinumab | The University of British Columbia | Megan Levings | Cures | 01-July-2018 to 30-June-2027 | $660.059,94 |
| Modulation of immune cell fate and function by the islet secretome in health and diabetes | The University of British Columbia | Lauar de Brito Monteiro | Cures | 01-March-2024 to 28-February-2027 | $243.055,00 |
| Engineering Stem Cell-Derived Islet Organoids with Immune Protection and Enhanced Vascular Support for Functional Cure of Diabetes | The University of British Columbia | Jia Zhao | Cures | 01-March-2026 to 28-February-2029 | $285.000,00 |
| BimT1D | The University of British Columbia | Jan Dutz | Cures | 01-September-2025 to 31-August-2029 | $2.488.315,00 |
| Clinical Phase II/III Trial to treat type 1 diabetes (UST1D2) | The University of British Columbia | Jan Dutz | Cures | 01-November-2020 to 31-December-2027 | $538.854,00 |